[New anthracyclines in the treatment of solid tumors in the advanced stage].
D000328:Adult; D000368:Aged; D000903:Antibiotics, Antineoplastic / Q000378:metabolism / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002945:Cisplatin / Q000627:therapeutic use; D003630:Daunorubicin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use*; D004341:Drug Evaluation; D015251:Epirubicin; D005260:Female; D006801:Humans; D015255:Idarubicin; D007700:Kinetics; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D009369:Neoplasms / Q000188:drug therapy*
D000903:Antibiotics, Antineoplastic; D015251:Epirubicin; D004317:Doxorubicin; D002945:Cisplatin; D015255:Idarubicin; D003630:Daunorubicin
Nuove antracicline nel trattamento di tumori solidi in fase avanzata.